FDA Approves OXCARBAZEPINE — Advagen Pharma Limited

# FDA Approves Generic Oxcarbazepine; Advagen Pharma Limited Enters Anticonvulsant Market Advagen Pharma Limited has received FDA approval for its generic oxcarbazepine oral formulation (ANDA077747), positioning the company to compete in the established anticonvulsant market as patent protections expire on branded alternatives. The approval could accelerate price competition in the seizure disorder treatment segment and expand patient access to this commonly prescribed neurological medication.